Tendas A - Search Results

1

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

Voso MT, Niscola P, Piciocchi A, Fianchi L, Maurillo L, Musto P, Pagano L, Mansueto G, Criscuolo M, Aloe-Spiriti MA, Buccisano F, Venditti A, Tendas A, Piccioni AL, Zini G, Latagliata R, Filardi N, Fragasso A, Fenu S, Breccia M; GROM (Gruppo Romano e Laziale MDS) and Basilicata MDS Registry. Voso MT, et al. Among authors: tendas a. Eur J Haematol. 2016 Apr;96(4):344-51. doi: 10.1111/ejh.12595. Epub 2015 Jun 21. Eur J Haematol. 2016. PMID: 26018238

2

Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile.

Breccia M, Voso MT, Maurillo L, Niscola P, Fianchi L, Aloe Spiriti MA, Buccisano F, Latagliata R, Pelliccia S, Fenu S, Tendas A, Alimena G. Breccia M, et al. Among authors: tendas a. Am J Hematol. 2014 May;89(5):565. doi: 10.1002/ajh.23677. Epub 2014 Feb 28. Am J Hematol. 2014. PMID: 24458879 Free article. Clinical Trial. No abstract available.

3

Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

Venditti A, Maurillo L, Buccisano F, Tamburini A, Del Poeta G, Del Principe MI, Panetta P, Consalvo MI, Mazzone C, Tendas A, Trawinska M, Forte V, Amadori S. Venditti A, et al. Among authors: tendas a. Leuk Lymphoma. 2003 Mar;44(3):445-50. doi: 10.1080/1042819021000037976. Leuk Lymphoma. 2003. PMID: 12688313 Review.

4

P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.

Del Principe MI, Del Poeta G, Maurillo L, Buccisano F, Venditti A, Tamburini A, Bruno A, Cox MC, Suppo G, Tendas A, Giannì L, Postorino M, Masi M, Del Principe D, Amadori S. Del Principe MI, et al. Among authors: tendas a. Br J Haematol. 2003 Jun;121(5):730-8. doi: 10.1046/j.1365-2141.2003.04343.x. Br J Haematol. 2003. PMID: 12780787 Free article.

5

Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.

Niscola P, Tendas A, Cupelli L, Giovannini M, Piccioni D, Scaramucci L, Dentamaro T, Del Poeta G, de Fabritiis P. Niscola P, et al. Among authors: tendas a. Acta Haematol. 2015;133(1):64-6. doi: 10.1159/000363643. Epub 2014 Aug 14. Acta Haematol. 2015. PMID: 25139255 No abstract available.

6

Managing myelodysplastic syndromes in very old patients: a teaching case report.

Niscola P, Palombi M, Trawinska MM, Tendas A, Giovannini M, Scaramucci L, Perrotti A, de Fabritiis P. Niscola P, et al. Among authors: tendas a. Clin Interv Aging. 2013;8:391-4. doi: 10.2147/CIA.S39536. Epub 2013 Apr 11. Clin Interv Aging. 2013. PMID: 23610516 Free PMC article.

7

Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia in an elderly patient: complete remissions of both diseases by rituximab-bendamustine regimen combined to hypomethylating therapy.

Palombi M, Niscola P, Tendas A, Trawinska MM, Scaramucci L, Giovannini M, Fratoni S, Perrotti A, de Fabritiis P. Palombi M, et al. Among authors: tendas a. J Chemother. 2013 Aug;25(4):247-9. doi: 10.1179/1973947813Y.0000000076. J Chemother. 2013. PMID: 23906078

8

Obstacles to adherence to azacitidine administration schedule in outpatient myelodysplastic syndrome and related disorders.

Tendas A, Lissia MF, Piccioni D, Tirimbelli L, Scaramucci L, Giovannini M, Dentamaro T, Perrotti A, de Fabritiis P, Niscola P. Tendas A, et al. Support Care Cancer. 2015 Feb;23(2):303-5. doi: 10.1007/s00520-014-2502-y. Epub 2014 Nov 5. Support Care Cancer. 2015. PMID: 25370894 No abstract available.

9

Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders.

Niscola P, Siniscalchi A, Tendas A, Scaramucci L, Fratoni S, de Fabritiis P, Caravita T. Niscola P, et al. Among authors: tendas a. Ann Hematol. 2015 Oct;94(10):1753-4. doi: 10.1007/s00277-015-2431-y. Epub 2015 Jun 20. Ann Hematol. 2015. PMID: 26088814 No abstract available.

10

Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience.

Cartoni C, Niscola P, Breccia M, Brunetti G, D'Elia GM, Giovannini M, Romani C, Scaramucci L, Tendas A, Cupelli L, de Fabritiis P, Foa R, Mandelli F. Cartoni C, et al. Among authors: tendas a. Leuk Lymphoma. 2009 Mar;50(3):387-91. doi: 10.1080/10428190802714024. Leuk Lymphoma. 2009. PMID: 19347728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page